Ra Pharmaceuticals (RARX) Forms $13.94 Double Bottom; Last Week Staffline Group Plc (LON:STAF) Analysts

November 14, 2017 - By Maria Brooks

Ra Pharmaceuticals Inc (RARX) formed double bottom with $13.52 target or 3.00% below today’s $13.94 share price. Ra Pharmaceuticals Inc (RARX) has $315.42M valuation. About 2,663 shares traded. Ra Pharmaceuticals Inc (NASDAQ:RARX) has 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 6 analysts covering Staffline Recruitment Group PLC (LON:STAF), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. Staffline Recruitment Group PLC had 57 analyst reports since July 23, 2015 according to SRatingsIntel. Liberum Capital maintained the stock with “Buy” rating in Tuesday, July 5 report. Panmure Gordon maintained Staffline Group Plc (LON:STAF) rating on Wednesday, January 27. Panmure Gordon has “Buy” rating and GBX 1450 target. Liberum Capital maintained Staffline Group Plc (LON:STAF) rating on Tuesday, September 29. Liberum Capital has “Buy” rating and GBX 1500 target. The firm earned “Buy” rating on Wednesday, July 26 by FinnCap. The rating was upgraded by Liberum Capital to “Buy” on Wednesday, January 27. FinnCap maintained the shares of STAF in report on Tuesday, September 26 with “Buy” rating. As per Thursday, January 5, the company rating was maintained by Credit Suisse. Liberum Capital maintained Staffline Group Plc (LON:STAF) on Wednesday, August 3 with “Buy” rating. The rating was maintained by FinnCap on Friday, February 3 with “Buy”. The company was maintained on Wednesday, January 25 by Liberum Capital. See Staffline Group Plc (LON:STAF) latest ratings:

10/11/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
16/10/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
26/09/2017 Broker: FinnCap Rating: Buy Old Target: GBX 1615.00 New Target: GBX 1615.00 Maintain
16/08/2017 Broker: Credit Suisse Rating: Underperform Old Target: GBX 1050.00 New Target: GBX 1000.00 DownGrade
31/07/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
26/07/2017 Broker: FinnCap Rating: Buy Old Target: GBX 1615.00 New Target: GBX 1615.00 Maintain
26/07/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Upgrade
04/07/2017 Broker: FinnCap Rating: Buy Old Target: GBX 1615.00 New Target: GBX 1615.00 Maintain
04/07/2017 Broker: Liberum Capital Rating: Hold Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
26/06/2017 Broker: Liberum Capital Rating: Hold Old Target: GBX 1350.00 New Target: GBX 1350.00 Downgrade

Among 3 analysts covering Ra Pharmaceuticals (NASDAQ:RARX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ra Pharmaceuticals had 5 analyst reports since August 24, 2017 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Thursday, August 24 report. The rating was maintained by Credit Suisse on Friday, November 10 with “Outperform”. The firm earned “Buy” rating on Tuesday, September 26 by Jefferies. RBC Capital Markets maintained the shares of RARX in report on Tuesday, October 24 with “Buy” rating.

Analysts await Ra Pharmaceuticals Inc (NASDAQ:RARX) to report earnings on March, 5. They expect $-0.82 EPS, down 12.33% or $0.09 from last year’s $-0.73 per share. After $-0.68 actual EPS reported by Ra Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts 20.59% negative EPS growth.

Staffline Group plc is a holding company, which is engaged in the provision of recruitment and outsourced human resource services to industry and services in the welfare to work arena and skills training. The company has market cap of 299.38 million GBP. The Firm has two divisions: Staffing Services, which includes the provision of temporary staff to customers, and PeoplePlus, which includes the provision of welfare to work and other training services. It has a 31.25 P/E ratio. The Company’s Staffing Services focuses on providing complete labor solutions in agriculture, food processing, manufacturing, e-retail, driving and the logistics sectors.

About 134,719 shares traded or 103.34% up from the average. Staffline Group Plc (LON:STAF) has 0.00% since November 14, 2016 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com